{
    "organizations": [],
    "uuid": "681b01fa9b4b3cc44cd1cdd2f867c888cb89ebac",
    "author": "",
    "url": "https://www.reuters.com/article/brief-reata-provides-program-update-on-p/brief-reata-provides-program-update-on-phase-2-rare-renal-clinical-trials-idUSASB0C7U0",
    "ord_in_thread": 0,
    "title": "BRIEF-Reata Provides Program Update On Phase 2 Rare Renal Clinical Trials",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27 (Reuters) - Reata Pharmaceuticals Inc:\n* REATA PROVIDES PROGRAM UPDATE ON PHASE 2 RARE RENAL CLINICAL TRIALS\n* REATA PHARMACEUTICALS INC - FIRST DATA FROM PHOENIX EXPECTED 2H18 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-28T00:47:00.000+02:00",
    "crawled": "2018-02-28T01:05:27.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "reata",
        "pharmaceutical",
        "inc",
        "reata",
        "provides",
        "program",
        "update",
        "phase",
        "rare",
        "renal",
        "clinical",
        "trial",
        "reata",
        "pharmaceutical",
        "inc",
        "first",
        "data",
        "phoenix",
        "expected",
        "2h18",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}